Cinoxacin: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk No edit summary |
imported>David E. Volk m (→External links) |
||
Line 12: | Line 12: | ||
== External links == | == External links == | ||
* {{DailyMed}} | * {{DailyMed}} | ||
* | * {{MedMaster}} | ||
* {{DrugBank}} |
Revision as of 12:59, 5 March 2008
Cinoxacin (Cinobac®) is an antibiotic drug use to treat urinary tract infections caused by many aerobic, gram-negative bacteria. It is active against susceptible strains of E. coli, Proteus mirabilis, Proteus vulgaris, Klebsiella pneumoniae, and Enterobacter species.
Mechanism of action
Cinoxacin binds to DNA and interferes with the synthesis of viral RNA and therefore inhibits the production of viral proteins.
Chemistry
Cinoxacin's IUPAC chemical name is 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid and its chemical formula is C12H10N2O5 (MW=262.2182 g/mol). It is related to oxolinic acid and nalidixic acid and it is active over the entire urinary pH range.
External links
- Cinoxacin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Template:MedMaster
- Template:DrugBank